Background: While popularly consumed for its perceived benefits as a sleeping aid, the impact of cannabis on sleep-wake regulation in clinical studies is inconclusive. The purpose of this study was to determine the relationship between cannabis use and nightly sleep duration in a nationally representative dataset.

Methods: A cross-sectional analysis of adults was undertaken using the National Health and Nutrition Examination Survey data from 2005 to 2018. Respondents were dichotomized as recent users or non-users if they had used or not used cannabis in the past 30 days, respectively. The primary outcome was nightly sleep duration, categorized as short (<6 hours), optimal (6-9 hours), and long (>9 hours). Multinomial logistic regression was used to adjust for sociodemographic and health-related covariates, and survey sample weights were used in modeling.

Results: From a sample representing approximately 146 million adults in the USA, 14.5% reported recent cannabis use. In an adjusted analysis, recent users were more likely than non-users to report both short sleep (OR 1.34, 95% CI 1.12 to 1.59, p<0.001) and long sleep (OR 1.56, 95% CI 1.25 to 1.96, p<0.001). Heavy users (≥20 of the past 30 days) were even more likely to be at the extremes of nightly sleep duration.

Discussion: Recent cannabis use was associated with the extremes of nightly sleep duration in a nationally representative sample of adults, with suggestions of a dose-response relationship. Our findings highlight the need to further characterize the sleep health of regular cannabis users in the population.

Download full-text PDF

Source
http://dx.doi.org/10.1136/rapm-2021-103161DOI Listing

Publication Analysis

Top Keywords

nightly sleep
12
sleep duration
12
cannabis nightly
8
2005 2018
8
users non-users
8
cannabis
5
sleep
4
duration adults
4
adults population
4
population analysis
4

Similar Publications

Melatonin has multiple proposed therapeutic benefits including antioxidant properties, circadian rhythm synchronisation and sleep promotion. Since these areas are also recognised risk factors for dementia, melatonin has been hypothesised to slow cognitive decline in older adults. Participants with Mild Cognitive Impairment (MCI) were recruited from the community for a 12-week randomised placebo-controlled parallel, feasibility trial of 25 mg oral melatonin nightly.

View Article and Find Full Text PDF

Introduction: Opioid use disorder (OUD) is a serious and persistent problem in the United States with limited non-pharmacological treatment options, especially for the concomitant sleep disorders experienced by most individuals with addiction. While new, non-invasive interventions such as low-intensity focused ultrasound (LIFU) have shown promise in targeting the brain regions impacted throughout addiction and recovery, the devices used are not amenable to outpatient treatment in their current form factor and cannot be used at night during sleep. To bridge this gap and provide a much-needed treatment option for repeated, at-home use, we developed a wearable LIFU device out-of-clinic use.

View Article and Find Full Text PDF

Crime impacts both the immediate victims and has indirect effects on the community. This study examined associations between daily neighborhood crime and actigraphy-assessed sleep outcomes using multilevel modeling. Data were from a longitudinal (14-day) study of 288 adolescents (M = 15.

View Article and Find Full Text PDF

Immediate Postoperative Changes After Expansion Pharyngoplasty and Hypoglossal Nerve Stimulation.

Laryngoscope

November 2024

Department of Otolaryngology, Massachusetts Eye and Ear, Boston, Massachusetts, U.S.A.

Article Synopsis
  • The study aimed to evaluate the effects of hypoglossal nerve stimulation (HGNS) and expansion pharyngoplasty (EP) on patients with obstructive sleep apnea (OSA) to understand potential respiratory complications post-surgery.
  • Thirty patients (19 received HGNS and 11 received EP) were monitored using the NightOwl Mini device for changes in the apnea-hypopnea index (AHI) and oxygen levels after surgery.
  • Results showed no significant changes in AHI after HGNS, indicating no need for extended overnight observation, whereas EP led to increased AHI and hypoxemia, suggesting tailored postoperative care is necessary for those patients.
View Article and Find Full Text PDF

Study Objectives: Current treatments for obstructive sleep apnoea (OSA) are ineffective or not tolerated in a proportion of patients. Other therapeutic options are needed and pharmaceuticals may provide an alternative. This randomised, double-blind, placebo-controlled, cross-over study examined the effect of combination acetazolamide and dronabinol (IHL-42X) at low, medium and high doses on OSA severity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!